Belgium and its companies at the forefront of the biotechnology industry in Europe Belgium is spearheading the European biotech industry. Meet some of the most successful cases of Belgian biotechnology companies. Belgium is one of the countries that provide the most to the biotech industry in Europe, as it has a total of more than[…]
OUAT! recently raised 500k€ with the Innovation Fund. The capital infusion will support the further development of HakoBio and the roll out of the software to new clients. OUAT! aims to facilitate the digital transformation of the life sciences industry. In increasingly intelligent and connected factories, OUAT! enables the men and women of the biopharmaceutical industry to achieve[…]
Univercells Holding recently raises €70 million with two rounds of capital increase with new investors. The capital infusion will support the development of GMP facilities and the capacity to foster distributed manufacturing and supply of biologics. Univercells recently completed their Series C second close, bringing the total raised to €70 million. The financing, which was over-subscribed,[…]
Many large investors have already set their sights on the Walloon company Univercells. Among them stands out the American billionaire George Soros; famous financier and philanthropist at the age of 90, Adjuvant Capital; a fund linked to the Bill Gates galaxy, the federal government through SFPI, and the Walloon government through SRIW. Bill Gates, as[…]
Digital Orthopaedics is an innovative e-Health company providing a comprehensive Clinical Decision Support System (CDSS) for musculoskeletal pathologies, for the foot and ankle in particular. Digital Orthopaedics’ ambition is to transform the planning and execution of orthopedic surgeries and treatment with the ultimate goal of personalizing orthopedic treatments through the innovative use of ideation, modeling and 3D[…]
June was a busy month for Digital Orthopaedics. During a webinar co-organized with Synopsys, the company’s engineers described how they generate patient-specific digital twins; a mechanical replica of the patient’s foot, using image & motion analysis. This event was followed by Simbio-M, another virtual conference focused on new technologies in the field of biomechanics and[…]
GOSSELIES, BELGIUM – FEBRUARY 14TH, 2020 — OncoDNA (“OncoDNA or “the Company”), the healthcare technology company making precision medicine a reality, today announced that it has completed a €19 million ($20 million) Series B equity financing. The new funding will support rapid international growth, accelerate software development and hiring initiatives. The round was led by Vesalius Biocapital[…]
We took part in the event “Anchoring Clinical Research in Belgium” jointly organized by BioWin and flanders.bio in Brussels where we had an interesting debate on funding opportunities for biomedical research and clinical trials development in a sector where Belgium is leading globally. Thank you to Bone Therapeutics, icometrix and Ayming Belgium for sharing the stage. […]
There is no excerpt because this is a protected post.
We are present at BioWinConnect 2018 to get last updates about incubation models and collaboration that could enforce our startup studio.
Any questions on business creation, dilutive and non-dilutive funding? We will be pleased to freely advise you at the upcoming MedTech Meetup 2019. Book your 10-minute face-to-face meeting now!
Proud to have supported a third of the biotech companies which are representing Belgium at BIO-Europe 2017 in Berlin, Europe’s largest life science partnering conference.
The Deloitte Technology Fast 50 competition is an annual selection of the 50 fastest-growing technology companies within Belgium. The initiative is designed to encourage and promote entrepreneurial, fast-growing technology companies. On Wednesday 19th of November 2015, OncoDNA was named “Most Disruptive Innovator” in the Rising Star category. This award recognises companies that have developed a[…]